Patents by Inventor Kelly Lyn Warfield

Kelly Lyn Warfield has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Iminosugars useful for the treatment of viral diseases
    Patent number: 10428022
    Abstract: Formula IA, and their use for treating viral infections.
    Type: Grant
    Filed: November 4, 2015
    Date of Patent: October 1, 2019
    Assignee: Emergent Virology LLC
    Inventors: Urban Ramstedt, Kelly Lyn Warfield, Anthony Treston
  • Methods of Treating Zika Virus Infection
    Publication number: 20190282558
    Abstract: This disclosure provides methods for treating or preventing a disease or condition caused by or associated with a Zika virus infection in a subject. The methods can comprise administering to a subject in need thereof an effective amount of an iminosugar compound as described herein.
    Type: Application
    Filed: May 16, 2017
    Publication date: September 19, 2019
    Applicant: Emergent Virology LLC
    Inventors: Anthony Michael TRESTON, Kelly Lyn WARFIELD
  • IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES
    Publication number: 20180273473
    Abstract: Formula IA, and their use for treating viral infections.
    Type: Application
    Filed: November 4, 2015
    Publication date: September 27, 2018
    Inventors: Urban RAMSTEDT, Kelly Lyn WARFIELD, Anthony TRESTON
  • Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides
    Patent number: 10023848
    Abstract: The present disclosure provides immunogenic compositions useful in prevention and treatment of Staphylococcus aureus infection. In particular, the disclosure provides methods of inducing an immune response against a panton-valentine leukocidin (PVL)-expressing S. aureus, methods of preventing or treating S. aureus infections, and composition for preventing or treating S. aureus infections.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: July 17, 2018
    Assignee: INTEGRATED BIOTHERAPEUTICS, INC
    Inventors: Mohammad Javad Aman, Rajan Prasad Adhikari, Hatice Karauzum, Jawad Sarwar, Sergey Shulenin, Sathya Venkataramani, Kelly Lyn Warfield, Tam Luong Nguyen
  • MONOCLONAL ANTIBODIES DIRECTED AGAINST ENVELOPE GLYCOPROTEINS FROM MULTIPLE FILOVIRUS SPECIES
    Publication number: 20170158753
    Abstract: The disclosure provides binding molecules, e.g., antibodies or antigen-binding fragments thereof, that can bind to orthologous epitopes found on two or more filovirus species or strains.
    Type: Application
    Filed: June 24, 2015
    Publication date: June 8, 2017
    Inventors: Mohammad Javad Aman, Frederick W. Holtsberg, Sergey Shulenin, Hong Vu, Katie A. Howell, Kelly Lyn Warfield
  • Compositions and Methods for Inhibiting Expression of a Gene from the Ebola Virus
    Publication number: 20160264972
    Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.
    Type: Application
    Filed: October 13, 2015
    Publication date: September 15, 2016
    Inventors: Sina Bavari, Kelly Lyn Warfield, Pamela Tan, Anna Borodovsky, Tatiana Novobrantseva, Antonin de Fougerolles
  • IMMUNOGENIC COMPOSITION COMPRISING ALPHA-HEMOLYSIN OLIGOPEPTIDES
    Publication number: 20160039888
    Abstract: The present invention provides immunogenic compositions useful in prevention and treatment of Staphylococcus aureus infection. In particular, the present invention provides methods of inducing an immune response against an alpha-hemolysin-expressing S. aureus, methods of preventing or treating S. aureus infections, and composition for preventing or treating S. aureus infections.
    Type: Application
    Filed: August 5, 2015
    Publication date: February 11, 2016
    Inventors: Mohammad Javad Aman, Rajan Prasad Adhikari, Hatice Karauzum, Kelly Lyn Warfield, Tam Luong Nguyen
  • Compositions and methods for inhibiting expression of a gene from the Ebola virus
    Patent number: 9187516
    Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.
    Type: Grant
    Filed: May 15, 2014
    Date of Patent: November 17, 2015
    Assignees: Alnylam Pharmaceuticals, Inc., The United States of America, as Represented by the Secretary of the Army
    Inventors: Sina Bavari, Kelly Lyn Warfield, Pamela Tan, Anna Borodovsky, Tatiana Novobrantseva, Antonin de Fougerolles
  • Immunogenic composition comprising alpha-hemolysin oligopeptides
    Patent number: 9109036
    Abstract: The present invention provides immunogenic compositions useful in prevention and treatment of Staphylococcus aureus infection. In particular, the present invention provides methods of inducing an immune response against an alpha-hemolysin-expressing S. aureus, methods of preventing or treating S. aureus infections, and composition for preventing or treating S. aureus infections.
    Type: Grant
    Filed: February 6, 2012
    Date of Patent: August 18, 2015
    Assignee: Integrated BioTherapeutics, Inc.
    Inventors: Mohammad Javad Aman, Rajan Prasad Adhikari, Hatice Karauzum, Kelly Lyn Warfield, Tam Luong Nguyen
  • Compositions and methods for inhibiting expression of CD45 gene
    Patent number: 8912316
    Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the CD45 gene.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: December 16, 2014
    Assignees: Alnylam Pharmaceuticals, Inc., The United States of America as represented by the Army
    Inventors: Antonin De Fougerolles, Pamela Tan, Anna Borodovsky, Tatiana Novobrantseva, Sina Bavari, Kelly Lyn Warfield
  • Immunogenic Composition Comprising Panton-Valentine Leukocidin (PVL) Derived Polypeptides
    Publication number: 20140308291
    Abstract: The present disclosure provides immunogenic compositions useful in prevention and treatment of Staphylococcus aureus infection. In particular, the disclosure provides methods of inducing an immune response against a panton-valentine leukocidin (PVL)-expressing S. aureus, methods of preventing or treating S. aureus infections, and composition for preventing or treating S. aureus infections.
    Type: Application
    Filed: November 30, 2012
    Publication date: October 16, 2014
    Inventors: Mohammad Javad Aman, Rajan Prasad Adhikari, Hatice Karauzum, Jawad Sarwar, Sergey Shulenin, Sathya Venkataramani, Kelly Lyn Warfield, Tam Luong Nguyen
  • Compositions and Methods for Inhibiting Expression of a Gene from the Ebola Virus
    Publication number: 20140243394
    Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.
    Type: Application
    Filed: May 15, 2014
    Publication date: August 28, 2014
    Applicants: Alnylam Pharmaceuticals Inc., The Government of the United States, as Represented by the Secretary of the Army
    Inventors: Sina Bavari, Kelly Lyn Warfield, Pamela Tan, Anna Borodovsky, Tatiana Novobrantseva, Antonin de Fougerolles
  • Compositions and methods for inhibiting expression of a gene from the Ebola virus
    Patent number: 8735369
    Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: May 27, 2014
    Assignees: Alnylam Pharmaceuticals, Inc., The United States of America, as represented by the Secretary of the Army
    Inventors: Sina Bavari, Kelly Lyn Warfield, Pamela Tan, Anna Borodovsky, Tatiana Novobrantseva, Antonin de Fougerolles
  • Immunogenic Composition Comprising Alpha-Hemolysin Oligopeptides
    Publication number: 20140079709
    Abstract: The present invention provides immunogenic compositions useful in prevention and treatment of Staphylococcus aureus infection. In particular, the present invention provides methods of inducing an immune response against an alpha-hemolysin-expressing S. aureus, methods of preventing or treating S. aureus infections, and composition for preventing or treating S. aureus infections.
    Type: Application
    Filed: February 6, 2012
    Publication date: March 20, 2014
    Applicant: Integrated Bio Therapeutics Inc.
    Inventors: Mohammad Javad Aman, Rajan Prasad Adhikari, Hatice Karauzum, Kelly Lyn Warfield, Tam Luong Nguyen
  • Compositions And Methods for Inhibiting Expression Of A Gene From the Ebola Virus
    Publication number: 20130225654
    Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.
    Type: Application
    Filed: September 26, 2012
    Publication date: August 29, 2013
    Inventors: Sina Bavari, Kelly Lyn Warfield, Pamela Tan, Anna Borodovsky, Tatiana Novobrantseva, Antonin de Fougerolles
  • COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD45 GENE
    Publication number: 20130065943
    Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the CD45 gene.
    Type: Application
    Filed: September 12, 2012
    Publication date: March 14, 2013
    Inventors: Antonin De Fougerolles, Pamela Tan, Anna Borodovsky, Tatiana Novobrantseva, Sina Bavari, Kelly Lyn Warfield
  • Compositions and methods for inhibiting expression of a gene from the ebola virus
    Patent number: 8354390
    Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.
    Type: Grant
    Filed: April 25, 2011
    Date of Patent: January 15, 2013
    Assignees: Alnylam Pharmaceuticals, Inc., The United States of America, as represented by the Secretary of the Army
    Inventors: Sina Bavari, Kelly Lyn Warfield, Pamela Tan, Anna Borodovsky, Tatiana Novobrantseva, Antonin de Fougerolles
  • Compositions and methods for inhibiting expression of CD45 gene
    Patent number: 8288525
    Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the CD45 gene.
    Type: Grant
    Filed: February 12, 2009
    Date of Patent: October 16, 2012
    Assignee: Alnylam Pharmaceuticals, Inc.
    Inventors: Antonin de Fougerolles, Pamela Tan, Anna Borodovsky, Tatiana Novobrantseva, Sina Bavari, Kelly Lyn Warfield
  • Antiviral Compounds and Methods of Using Thereof
    Publication number: 20120035198
    Abstract: Disclosed herein are compounds which exhibit antiviral activity against a plurality of viruses belonging to different families such as Bornaviridae, Filoviridae, Paramyxoviridae, Rhabdoviridae, Arenaviridae, Bunyaviridae, Orthomyxoviridae, and Poxviridae. Thus, methods of preventing, inhibiting, or reducing the viral activity of various viruses are provided as well as methods of treating viral infections.
    Type: Application
    Filed: July 8, 2011
    Publication date: February 9, 2012
    Inventors: Mohammad Javad Aman, Sina Bavari, James C. Burnett, Kelly Lyn Warfield
  • Compositions And Methods For Inhibiting Expression Of A Gene From The Ebola Virus
    Publication number: 20110201671
    Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) FOR INHIBITING THE expression of a gene from the Ebola virus.
    Type: Application
    Filed: April 25, 2011
    Publication date: August 18, 2011
    Applicant: ALNYLAM PHARMACEUTICALS, INC.
    Inventors: Sina Bavari, Kelly Lyn Warfield, Pamela Tan, Anna Borodovsky, Tatiana Novobrantseva, Antonin de Fougerolles